Tag: inflarc
Inflarx’s Covid drug approved in the US – stock rises sharply
Niels Riedemann The founder and CEO of Inflarx sees hope in the drug for seriously ill Covid patients. (Photo: InflaRx) Frankfurt An approval success that many investors no longer expected…
Biontech is setting itself apart from the rest of the industry more and more
Frankfurt The success of Mainz-based Biontech SE in Covid vaccine development has put the German biotech industry in the spotlight. However, hopes that the rise of the mRNA and oncology…
Hope for better therapies for seriously ill Covid patients
CEO Niels Riedemann According to Inflarx boss and founder Niels Riedemann, previous talks with the US authorities were very encouraging. (Photo: InflaRx) Frankfurt With two new developments from the biotech…
Munich-based biotech company plans to go public on the Nasdaq
Radionuclide Cancer Therapy ITM has been producing radioisotopes for pharmaceutical companies from all over the world since the company was founded. (Photo: ITM) Frankfurt According to financial circles, the Munich-based…